Neuberger Berman Group’s Pacific Biosciences PACB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-28,208
| Closed | -$51.6K | – | 2026 |
|
|
2024
Q4 | $51.6K | Buy |
28,208
+892
| +3% | +$1.63K | ﹤0.01% | 1876 |
|
|
2024
Q3 | $46.4K | Buy |
+27,316
| New | +$46.4K | ﹤0.01% | 1867 |
|
|
2024
Q1 | – | Sell |
-621,771
| Closed | -$6.1M | – | 1894 |
|
|
2023
Q4 | $6.1M | Buy |
621,771
+143,661
| +30% | +$1.41M | 0.01% | 868 |
|
|
2023
Q3 | $3.99M | Buy |
478,110
+65,361
| +16% | +$546K | ﹤0.01% | 929 |
|
|
2023
Q2 | $5.49M | Buy |
+412,749
| New | +$5.49M | ﹤0.01% | 864 |
|